BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 47 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $592,301 | +96209.1% | 15,129 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $615 | -2.8% | 15,129 | 0.0% | 0.02% | -10.0% |
| Q1 2023 | $633 | -3.9% | 15,129 | 0.0% | 0.02% | -9.1% |
| Q4 2022 | $659 | -99.9% | 15,129 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $587,000 | +9.1% | 15,129 | +19.2% | 0.02% | +15.8% |
| Q2 2022 | $538,000 | -6.9% | 12,695 | 0.0% | 0.02% | +5.6% |
| Q1 2022 | $578,000 | +26.2% | 12,695 | +34.3% | 0.02% | +28.6% |
| Q4 2021 | $458,000 | +1.8% | 9,450 | 0.0% | 0.01% | -6.7% |
| Q3 2021 | $450,000 | -1.7% | 9,450 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $458,000 | +4.8% | 9,450 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $437,000 | -2.9% | 9,450 | 0.0% | 0.02% | -11.8% |
| Q4 2020 | $450,000 | +53.1% | 9,450 | +38.0% | 0.02% | +30.8% |
| Q3 2020 | $294,000 | +10.1% | 6,850 | +4.6% | 0.01% | 0.0% |
| Q2 2020 | $267,000 | – | 6,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nova R Wealth, Inc. | 400,376 | $15,674,710 | 10.82% |
| Cornerstone Advisory, LLC | 102,883 | $4,027,856 | 0.70% |
| Alterity Financial Group, LLC | 9,346 | $365,885 | 0.58% |
| Owen LaRue, LLC | 11,926 | $466,903 | 0.51% |
| Semus Wealth Partners LLC | 12,337 | $482,994 | 0.45% |
| PRIMORIS WEALTH ADVISORS, LLC | 7,235 | $283,278 | 0.34% |
| 1607 Capital Partners, LLC | 88,092 | $3,448,802 | 0.26% |
| CORRADO ADVISORS, LLC | 9,285 | $363,508 | 0.25% |
| Founders Financial Alliance, LLC | 10,623 | $415,905 | 0.18% |
| Diversified, LLC | 12,243 | $479,300 | 0.12% |